That’s how Citigroup’s Paul Lejuez and team described Tiffany’s (TIF) fourth-quarter earnings and 2016 guidance in a note this morning:
Adj EPS of $1.46 vs cons and our $1.40. Comps -5% worldwide (constant Fx, in line with Holiday results), with the Americas -8% (in line with Holiday), Europe -3% (Holiday -2%), Japan +10% (in line with Holiday), and Asia-Pac....More>>>
SiteOne Landscape Supply (NYSE:SITE) had its target price hoisted by Deutsche Bank from $78.00 to $81.00 in a report released on Friday morning. The firm currently has a buy rating on the industrial products company’s stock.
SITE has been the topic of a number of other research reports. Barclays set a $65.00 target price on SiteOne Landscape Supply and gave the company a hold rating....More>>>
A review of inflation, interest rates, capacity utilization, and inventory point more towards the middle stage of an expansion.
Basic Materials companies like chemical producers typical do well mid-cycle. Huntsman International has a solid balance sheet, lots of dry powder for strategic opportunities, strong margins, and industry-leading efficiency returns.
The stock looks relatively....More>>>
More often than not, dividend stocks are the “X-Factor” that propels the average investment portfolio to greatness over the long run. That’s because dividend stocks offer three key advantages that cause investors to seek them out.
The promises and perils of dividend investing
To begin with, dividend stocks are usually beacons of profitability. A company’s....More>>>
Nonprofit organization Oxfam presented a state of the world’s wealth analysis before Davos, a gathering of the world’s richest and most powerful people. Among the conclusions of the study is that the world adds a new billionaire every other day.
Another major conclusion of the study is that 1% of the world’s population controls 82% of the world’s wealth:
If you ownJohnson & Johnson (NYSE:JNJ) stock, there's a really good chance that you do so because of its dividend. The healthcare giant is a longtime favorite for income investors, in large part due to its sterling track record of 56 consecutive years of dividend increases.
Takeda Pharmaceutical Co. (NASDAQOTH:TKPYY) announced late last month its interest in making an offer to acquire Shire (NASDAQ:SHPG), and according to Shire, Takeda has followed through with three separate bids. So far, Shire's board of directors has rejected the offers as inadequate, but that do
Gerber Kawasaki Wealth & Investment Management acquired a new stake in AbbVie Inc (NYSE:ABBV) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 2,912 shares of the company’s stock, valued at approximately $275,00
Ablynx (OTCMKTS: ABLYF) is one of 94 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its competitors? We will compare Ablynx to related companies based on the strength of its earnings, dividends, profitability, institutio